In this randomized , parallel-group , open-label , single-center , case-controlled , prospective study , 65 participants ( 70 hands ) aged 18-75 years with clinical & electrodiagnostic evidences of CTS were randomized to receive either the EMLA cream ( n = 30 patients , 35 hands , group 1 ) or one injection of methylprednisolone acetate 40 mg at wrist ( n = 35 patients , group 2 ) .
